[
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-1",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#definitiongeneral459160",
    "clean_content": "Definition / general\n\n* Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell (FDC) / fibroblastic reticular cell (FRC) tumor (ICC, 2022) / EBV positive inflammatory follicular dendritic cell (FDC) sarcoma (WHO, 5th edition) is an EBV driven indolent malignancy of FDC / FRC phenotype with a prominent inflammatory background* Encompasses extranodal lesions previously referred to as EBV positive inflammatory pseudotumor (IPT); nodal EBV positive IPT as well as EBV negative FDC sarcoma are excluded"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-2",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#essentialfeatures459161",
    "clean_content": "Essential features\n\n* Extranodal EBV positive mesenchymal neoplasm with a phenotypic spectrum ranging from FDCs to FRCs associated with a prominent polymorphic inflammatory background* Previously considered a variant of FDC sarcoma, it has now been recognized as a distinct entity by both the WHO, 5th edition and the ICC, 2022* Nodal cases reported as inflammatory pseudotumor are excluded* Usually involves middle aged women of Asian descent* Solitary, asymptomatic splenic mass is the most common finding but it can also affect the liver and rarely, the colon and pancreas"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-3",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#terminology459162",
    "clean_content": "Terminology\n\n* Inflammatory pseudotumor of the spleen, EBV positive* Inflammatory pseudotumor-like follicular / fibroblastic dendritic cell sarcoma* Inflammatory pseudotumor-like follicular dendritic cell tumor"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-4",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#icdcoding459163",
    "clean_content": "ICD coding\n\n* ICD-O: [9758/3](https://iris.who.int/bitstream/handle/10665/96612/9789241548496_eng.pdf?sequence=1#page=97) - follicular dendritic cell sarcoma* ICD-10: [C96.7](https://icd.who.int/browse10/2019/en#/C96.7) - other specified malignant neoplasms of lymphoid, hematopoietic and related tissue* ICD-11: [2B31.Y](https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f2022303330%2fmms%2fother) - other specified histiocytic or dendritic cell neoplasms"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-5",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#epidemiology459164",
    "clean_content": "Epidemiology\n\n* Lesion occurs predominantly in middle aged Asian women and is by definition associated with EBV infection* F:M = 10:1 to 7:2 ([Am J Surg Pathol 2001;25:721](11395549), [Am J Surg Pathol 2021;45:765](33264138))* Age distribution ranges between 19 and 67 years; mean age of 49 - 58 years ([Am J Surg Pathol 2023;47:476](36574358), [Am J Surg Pathol 2021;45:765](33264138), [Am J Surg Pathol 2001;25:721](11395549))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-6",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#sites459165",
    "clean_content": "Sites\n\n* Spleen is the most frequent site of involvement, followed by the liver ([Am J Surg Pathol 2023;47:476](36574358), [Am J Surg Pathol 2021;45:765](33264138), [Am J Surg Pathol 2001;25:721](11395549))* Rare reports in the gastrointestinal (GI) tract and the lungs ([Hum Pathol 2015;46:1956](26477709), [Case Rep Pathol 2019:2019:2648123](31885993), [Am J Surg Pathol 2023;47:476](36574358))* Nodal IPT cases are excluded; in these cases, EBV is consistently absent in the mesenchymal component ([Hum Pathol 2015;46:1956](26477709))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-7",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#pathophysiology459166",
    "clean_content": "Pathophysiology\n\n* Steps involved in the development of these neoplasms are poorly characterized* CD21 may allow entry of EBV in the FDCs ([Proc Natl Acad Sci U S A 1984;81:4510](6087328), [Virology 2016:494:23](27061054), [Nat Rev Microbiol 2019;17:691](31477887))\n    + Mechanism of EBV infection in cases with an FRC phenotype is less clear* How EBV promotes neoplastic transformation in mesenchymal cells is not fully understood* Distinct from inflammatory myofibroblastic tumors in which ALK or other tyrosine kinase receptors are involved\n        + MAPK pathway alterations have not been reported ([Am J Surg Pathol 2001;25:721](11395549))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-8",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#etiology459167",
    "clean_content": "Etiology\n\n* Neoplastic cells are positive for EBV encoded small RNA (EBER)* Frequent association with EBV genotype A, f variant and with a 30 base pair deletion in exon 3 of the *LMP1* gene, demonstrating the presence of a clonal EBV genome ([Histopathology 2016;69:883](27146079))\n    + This implies that EBV plays a role in the etiology of these lesions"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-9",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#clinicalfeatures459169",
    "clean_content": "Clinical features\n\n* Usually asymptomatic finding during imaging work up for other reasons* Systemic symptoms can be seen, including fever, fatigue and weight loss* Abdominal distension and pain with or without palpable abdominal mass* Colonic cases can present with positive fecal occult blood test ([Am J Surg Pathol 2021;45:765](33264138))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-10",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#diagnosis459170",
    "clean_content": "Diagnosis\n\n* Clinical, laboratory and imaging findings are largely nonspecific* Endoscopy shows a polypoid mass in cases involving the GI tract ([Hum Pathol 2015;46:1956](26477709))* Diagnosis requires histopathological demonstration of characteristic morphology, immunophenotype and EBER positivity by the WHO criteria; these are best evaluated on excisional specimens, including splenectomies"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-11",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#laboratory459171",
    "clean_content": "Laboratory\n\n* Nonspecific inflammatory reaction, including anemia, hypergammaglobulinemia, elevated C reactive protein"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-12",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#radiologydescription459172",
    "clean_content": "Radiology description\n\n* Solitary, well defined hypodense mass in the affected organ ([J Comput Assist Tomogr 2018;42:399](29287022))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-13",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#radiologyimages459173",
    "clean_content": "Radiology images\n\nImages hosted on other servers:  \n\n[![Liver mass on MRI](https://www.pathologyoutlines.com/thumb/lymphnodesEBVposinflamm_radio1.jpeg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354642/figure/F1/)\n\nLiver mass on MRI"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-14",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#prognosticfactors459174",
    "clean_content": "Prognostic factors\n\n* EBV positive FDC / FRC is an indolent tumor with a propensity for local recurrences in later stages of the disease* Location seems to be important for the prognosis, with splenic cases showing fewer recurrences than cases in the liver ([Int J Clin Exp Pathol 2014;7:2421](24966952), [Am J Surg Pathol 2001;25:721](11395549))* Distant metastases are rare and have been reported in the lungs and the spine* Overall mortality rate is 10% for liver cases* Colonic cases do not seem to recur and can be cured by complete excision ([Hum Pathol 2015;46:1956](26477709))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-15",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#casereports459175",
    "clean_content": "Case reports\n\n* 42 year old woman with a polypoid mass in the ascending colon ([Hum Pathol 2015;46:1956](26477709))* 55 year old woman with a 20 cm liver mass ([Front Med (Lausanne) 2023:10:1192998](37476617))* 70 year old woman with a pancreatic mass ([Case Rep Pathol 2019:2019:2648123](31885993))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-16",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#treatment459176",
    "clean_content": "Treatment\n\n* Surgical excision alone is the treatment of choice ([Am J Surg Pathol 2023;47:476](36574358))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-17",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#grossdescription459178",
    "clean_content": "Gross description\n\n* Solitary, large and well circumscribed mass with a broad size range from 1.5 cm up to 20 cm ([Am J Surg Pathol 2023;47:476](36574358), [Front Med (Lausanne) 2023:10:1192998](37476617))* Cut surface is smooth, white to tan and often shows areas of hemorrhage and necrosis"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-18",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#grossimages459179",
    "clean_content": "Gross images\n\nContributed by Elaine S. Jaffe, M.D.  \n\n[![Splenic mass](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe01.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe01.jpg)\n\nSplenic mass\n\n  \n  \nImages hosted on other servers:  \n\n[![Solitary splenic nodule](https://www.pathologyoutlines.com/thumb/lymphnodesEBVposinflamm_gross1.jpeg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069939/figure/fig01/)\n\nSolitary splenic nodule\n\n[![Pancreatic nodule](https://www.pathologyoutlines.com/thumb/lymphnodesEBVposinflamm_gross2.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915151/figure/fig1/)\n\nPancreatic nodule"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-19",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#microscopichistologicdescription459182",
    "clean_content": "Microscopic (histologic) description\n\n* Neoplastic cells are spindled to oval, with vesicular chromatin, a small, central nucleolus and indistinct cytoplasmic borders* Binucleate cells with a kissing nuclei appearance can be noted in cases with FDC differentiation* Neoplastic cells form loose fascicles with a storiform appearance* Rich inflammatory background composed of small lymphocytes, plasma cells and histiocytes; eosinophils can be present ([Hum Pathol 1995;26:1093](7557942), [Am J Surg Pathol 2001;25:721](11395549))* In some cases, the inflammatory component can obscure the sparsely distributed neoplastic cells* Cytologic atypia is variable; it can range from subtle, with cells showing delicate nuclear membranes, to prominent with Hodgkin / Reed-Sternberg (HRS)-like cells ([Am J Surg Pathol 2001;25:721](11395549))* Necrosis can be seen and it has not been consistently associated with more aggressive behavior ([Am J Surg Pathol 2001;25:721](11395549), [Histopathology 2016;69:883](27146079), [Am J Surg Pathol 2021;45:765](33264138))* Cases referred to as having a hemangioma-like appearance due to the prominence of blood vessel wall hyaline and fibrinoid degeneration have been reported ([Am J Surg Pathol 2023;47:476](36574358))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-20",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#microscopichistologicimages459183",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Elaine S. Jaffe, M.D., Shunyou Gong, M.D., Ph.D. and João Víctor Alves de Castro, M.D.  \n\n[![Spindle cells in an inflammatory background](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe02.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe02.jpg)\n\nSpindle cells in an inflammatory background\n\n[![Cytologic features and background](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe03.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe03.jpg)\n\nCytologic features and background\n\n[![Fibrinoid necrosis](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe04.jpg)\n\nFibrinoid necrosis\n\n[![Colonic lesion](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe05.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe05.jpg)\n\nColonic lesion\n\n[![Interface between spleen and tumor](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro01.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro01.jpg)\n\nInterface between spleen and tumor\n\n  \n\n[![Vascular damage and granulomas](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro02.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro02.jpg)\n\nVascular damage and granulomas\n\n[![Inflammatory background obscuring neoplastic cells](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro03.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro03.jpg)\n \n[![Inflammatory background obscuring neoplastic cells](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro04.jpg)\n\nInflammatory background obscuring neoplastic cells\n\n[![SMA immunohistochemistry](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe06.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe06.jpg)\n\nSMA IHC\n\n[![Double staining for SMA / EBER](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe08.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe08.jpg)\n\nDouble staining for SMA / EBER"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-21",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#cytologydescription459185",
    "clean_content": "Cytology description\n\n* Fine needle aspiration biopsy smears, touch imprints and scrape preparations show spindle cells with vesicular, atypical nuclei and delicate cytoplasmic processes distributed singly or in syncytial clusters ([Diagn Cytopathol 2008;36:42](18064686))* Nuclear grooves and prominent nucleoli can be seen* Cellularity ranges from hypo to hypercellular smears* Background is polymorphic and is rich in lymphocytes, plasma cells and histiocytes; can be hemorrhagic or necrotic* Immunohistochemistry is mandatory for the diagnosis (see [Positive stains](https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#EBVposstains))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-22",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Cytology images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#cytologyimages459186",
    "clean_content": "Cytology images\n\nImages hosted on other servers:  \n\n[![Syncytial group of tumor cells](https://www.pathologyoutlines.com/thumb/lymphnodesEBVposinflamm_cyto1.jpg)](https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.20744#page=2)\n\nSyncytial group of tumor cells"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-23",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#positivestains459189",
    "clean_content": "Positive stains\n\n* FDC differentiation is demonstrated by at least a subset of cells positive for one or more markers\n  + [CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html)+ [CD23](https://www.pathologyoutlines.com/topic/cdmarkerscd23.html)+ [CD35](https://www.pathologyoutlines.com/topic/cdmarkerscd30to39.html#cd35)+ [D2-40](https://www.pathologyoutlines.com/topic/stainsD240.html)+ **Clusterin**+ **CNA.42**+ [CXCL13](https://www.pathologyoutlines.com/topic/stainsCXCL13.html)+ [SSTR2](https://www.pathologyoutlines.com/topic/stainsSSTR2a.html)* FRC differentiation can be suggested by positivity for [smooth muscle actin (SMA)](https://www.pathologyoutlines.com/topic/stainsalphasmoothmuscleactin.html)* Cases with FRC differentiation may or may not be positive for FDC markers* [EBER](https://www.pathologyoutlines.com/topic/stainseber1.html) positivity in the spindle cells is required for the diagnosis\n        + EBV latency pattern is not consistently reported but [latent membrane protein 1 (LMP1)](https://www.pathologyoutlines.com/topic/stainseber1.html) is positive in 72 - 90% of cases evaluated ([Int J Clin Exp Pathol 2014;7:2421](24966952), [Histopathology 2016;69:883](27146079))* [IgG4](https://www.pathologyoutlines.com/topic/stainsigg4.html) positive plasma cells can be present ([Am J Surg Pathol 2023;47:476](36574358))"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-24",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#negativestains459190",
    "clean_content": "Negative stains\n\n* [ALK](https://www.pathologyoutlines.com/topic/stainsalk.html)* [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html)* [Desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html)* [h-caldesmon](https://www.pathologyoutlines.com/topic/stainscaldesmon.html)* [S100](https://www.pathologyoutlines.com/topic/stainsS100.html)* References: [Am J Surg Pathol 2001;25:721](11395549), [Int J Clin Exp Pathol 2014;7:2421](24966952)"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-25",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#molecularcytogeneticsdescription459195",
    "clean_content": "Molecular / cytogenetics description\n\n* *ALK* and other tyrosine kinase gene rearrangements are negative by FISH and sequencing methods, including NGS"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-26",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#molecularcytogeneticsimages459196",
    "clean_content": "Molecular / cytogenetics images\n\nContributed by João Víctor Alves de Castro, M.D. and Elaine S. Jaffe, M.D.  \n\n[![EBER ISH](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe09.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammJaffe09.jpg)\n\nEBER ISH\n\n[![EBER positive spindle cells](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro05.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesEBVposinflammCastro05.jpg)\n\nEBER positive spindle cells"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-27",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#samplepathologyreport459198",
    "clean_content": "Sample pathology report\n\n* Liver, left, partial hepatectomy:\n  + Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor (ICC, 2022) / EBV positive inflammatory follicular dendritic cell sarcoma (see comment)+ Comment: Histologic sections reveal effacement of the liver architecture within the grossly described mass by an atypical lymphoplasmacytic infiltrate. The infiltrate is composed predominantly of small lymphocytes with mature chromatin and numerous plasma cells. There are rare scattered atypical cells with elongated nuclei. Fibrinoid deposition is present around several vessels in addition to areas of hyalinization. Within the areas of hyalinization, there are numerous large vessels. While scattered islands of hepatocytes are present, normal portal areas with bile ducts within the mass lesion are rare.+ Within the lesion, there are rare scattered atypical, spindled appearing cells that are positive for CD21 and more often SMA. Clusterin is focally positive. CD20 and CD3 highlight B and T cells in aggregates respectively, with a predominance of T cells. EBV ISH highlights numerous cells, some with a spindled morphology and others that are more rounded. CD34 and SMA highlight sinusoidal spaces while keratin 7 highlights bile ducts, which are decreased in amount.+ Given the patient's clinical presentation in conjunction with rare CD21, SMA and EBV positive spindled cells in the mass lesion, this case is best felt to represent an Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor (ICC, 2022) / EBV positive inflammatory follicular dendritic cell sarcoma. The vessels and pattern of bile duct loss within the lesion are unusual. It is unclear whether the EBV positive spindle cell proliferation has distorted the underlying liver parenchyma, which then adapted to a predominantly arterial supply.+ Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor is the terminology currently used for the lesion also known as inflammatory pseudotumor. These occur in extranodal locations, including spleen, liver and more rarely GI tract. While previously referred to as sarcoma, when localized, the process has a good prognosis without significant risk for dissemination. This is an EBV driven lesion, in which the EBV positive cells are thought to be either FDCs or fibroblastic reticular cells (SMA positive)."
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-28",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#differentialdiagnosis459199",
    "clean_content": "Differential diagnosis\n\n* [Inflammatory myofibroblastic tumor](https://www.pathologyoutlines.com/topic/softtissueinflammyofibro.html):\n  + Presence of *ALK* rearrangements* [EBV associated smooth muscle tumor](https://www.pathologyoutlines.com/topic/softtissueebv.html):\n    + Clinical setting of immunodeficiency (HIV, posttransplant or rarely primary immunodeficiency)+ Eosinophilic cytoplasm with myoid features+ Positive for [desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html)* [IgG4 related disease](https://www.pathologyoutlines.com/topic/kidneyigg4related.html):\n      + Clinical criteria, including increase in serum IgG4* [Follicular dendritic cell sarcoma](https://www.pathologyoutlines.com/topic/lymphnodesfdcsarcoma.html):\n        + [EBER](https://www.pathologyoutlines.com/topic/stainseber1.html) negative+ Can present as nodal disease+ Usually much more tumor cell rich, with only a sprinkling of small lymphocytes* [Fibroblastic reticular cell tumor](https://www.pathologyoutlines.com/topic/lymphnodesfibroblasticreticulumcellsarcoma.html):\n          + [EBER](https://www.pathologyoutlines.com/topic/stainseber1.html) negative+ Positive for [cytokeratin](https://www.pathologyoutlines.com/topic/stainsckgeneral.html) and [desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html)* [Interdigitating dendritic cell sarcoma](https://www.pathologyoutlines.com/topic/lymphnodesinterdigitatingreticulum.html):\n            + [EBER](https://www.pathologyoutlines.com/topic/stainseber1.html) negative+ [S100](https://www.pathologyoutlines.com/topic/stainsS100.html) positive* [Hodgkin lymphoma](https://www.pathologyoutlines.com/topic/lymphomanonBclassic.html):\n              + Positive for [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html) and weak [PAX5](https://www.pathologyoutlines.com/topic/stainspax5.html)+ Lacks FDC markers"
  },
  {
    "id": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt-29",
    "source_document": "ebv-positive-inflammatory-follicular-dendritic-cell--fibroblastic-reticular-cell-tumor_45547_1750165657.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html#additionalreferences459200",
    "clean_content": "Additional references\n\n* [WHO Classification of Tumours Editorial Board: Haematolymphoid Tumours, 5th Edition, 2024](https://www.amazon.com/exec/obidos/ASIN/9283245202/pathologyoutl-20)"
  }
]